Fate Therapeutics Inc.

Fate Therapeutics' iPSC Technology Awarded Top Industry Honors for Small Molecule and Protein Reprogramming Breakthroughs.
Biotech Week; 1/6/2010; 1187 words; Fate Therapeutics, Inc. announced that the Company's...These notable awards recognize Fate Therapeutics for advancing minimally invasive...Technology, Therapy, Treatment, Fate Therapeutics Inc. This article was prepared by Biotech...

Receptos Completes $25M Series a Financing.
Cancer Weekly; 12/8/2009; 995 words; ...Chemistry at Conforma Therapeutics prior to the acquisition...development of novel therapeutics directed at high-value...Paul Grayson (CEO, Fate Therapeutics). For more information...Keywords: Biogen Idec Inc., Biopharmaceuticals...

Fate Therapeutics Closes $30 Million Series B Financing.
Blood Weekly; 12/3/2009; 1023 words; Fate Therapeutics, Inc. announced that it has completed a...Wolchko, chief financial officer of Fate Therapeutics. "With this Series B...Cell Research, Therapy, Treatment, Fate Therapeutics Inc. This article was prepared by Blood...

Receptos Completes $25M Series A Financing.
Business Wire; 11/23/2009; 929 words; ...DIEGO -- Receptos, Inc., a privately held...Chemistry at Conforma Therapeutics prior to the acquisition...development of novel therapeutics directed at high-value...Paul Grayson (CEO, Fate Therapeutics). For more information...

Fate Raises $30M in Series B to Advance Stem Cell Product.
BIOWORLD Today; 11/16/2009; 1187 words; Staff Writer Fate Therapeutics Inc. has lengthened its cash runway...cell therapy delivery models, Fate is focused on adult stem cell...Pharmaceuticals Inc. and Alios BioPharma Inc. But Aileron Therapeutics Inc. may have set a new record in...